Dylan Williams
@dylwil.bsky.social
120 followers 150 following 46 posts
Alzheimer's Research UK Senior Fellow, University College London. Studying the molecular epidemiology of dementia.
Posts Media Videos Starter Packs
dylwil.bsky.social
Do any pre-print servers for biomedical sciences accept Perspective or Comment articles?

Most seem to refuse these types of M/S. I'd like to give some draft articles indexed / searchable presence whilst they get reviewed (& likely rejected) by journals, i.e. not just posting them to Github
Reposted by Dylan Williams
michelnivard.bsky.social
Apply to do a PhD with me, Laura Corbin, Gareth Hawkes and George Davey Smith ( @mendelrandom.bsky.social) in Bristol on identifying rare effects on health using new and innovative methods. Amazing team, great educational environment, lovely city. Forward to your undergrads wrapping up!
Shining a light on the un-common to identify novel health risk-factors - GW4 BioMed MRC DTP
Project Code MRCPHS26Br Nivard Project Type Dry lab Research Theme Population Health Science Project Summary Download Summary Complex traits such as body mass index and height are influenced by a mixt...
gw4biomed.ac.uk
Reposted by Dylan Williams
emmylooroll.bsky.social
Last chance to sign up for our MR course next week folks!
emmylooroll.bsky.social
Our in-person Mendelian randomisation course is back at University College London this autumn. Join us in Bloomsbury, 16th-18th September 2025.

Tutors: Emma Anderson, Dylan Williams, Neil Davies
Guest lecturer: Eleanor Sanderson

onlinestore.ucl.ac.uk/conferences-...
D79 Mendelian Randomization | UCL Online Store
Abstract This course covers the fundamental developments in Mendelian randomization and gives practical explanations about how to apply MR to applied resea
onlinestore.ucl.ac.uk
dylwil.bsky.social
Alas, my data vis is not that pretty
dylwil.bsky.social
Which is when by the way? I will come to Bristol for it if I haven't missed it!
dylwil.bsky.social
That could be the title of your inaugural lecture?
dylwil.bsky.social
@michelnivard.bsky.social you're at least a bluefin tuna of statistical genetics mate!
dylwil.bsky.social
Just came across this graphical abstract for a paper. No idea what they were going for with the whale and rainbow, but at least it is very calming
dylwil.bsky.social
Finally grappled w/ UKB-RAP to update a UK Biobank analysis in past week. Happy to report my sanity is (just about) still intact and I only wasted ~£8 of credit (£5 on a job left running overnight, £3 on other incompetence). Facilitated greatly by ukbrapR by @lcpilling.bsky.social, big thanks Luke!
dylwil.bsky.social
@erictopol.bsky.social That is quite a strong conclusion to make from a subgroup analysis with N=29 from a phase 2 trial (and where, IMO, such large effect size stretches plausibility)
Reposted by Dylan Williams
dylwil.bsky.social
I love this paper ... so many insights, inc importance of ubiquitous exposures, a clear explanation for flaws of heritability (and analysis of variance more generally), and clarification of differences in "causes of cases & causes of incidence" by Rose, which I always thought obtuse and misleading
tomayates.bsky.social
Needed to revisit this great Neal Pearce paper today

'a factor that discourages investigation of near-ubiquitous risk factors is the continued misuse of measures such as the percentage of population variation explained to identify ‘major’ risk factors for disease, genetic or non-genetic'

#EpiSky
Epidemiology in a changing world: variation, causation and ubiquitous risk factors
Abstract. We are all living in the era of globalization and, like it or not, it is going to change the way we practise epidemiology, the kinds of questions
academic.oup.com
dylwil.bsky.social
Arising for a few reasons inc little incidence in 'unexposed' group (e2 homozygotes), limited outcome ascertainment in the cohort, imprecision for PAFs at each exposure level aggregating. Less problematic considering large point estimates for the PAFs produced every time (and a strong prior here)
Reposted by Dylan Williams
michelnivard.bsky.social
This is VERY big genetics & health news, Regeneron (Pharmaceutical company with v strong genetics in medicine arm) is going to buy 23andme. investor.regeneron.com/news-release...
investor.regeneron.com
dylwil.bsky.social
...Some feedback from last year’s course:
“The entire course was excellent. Lots of helpful information, engaging content, very helpful and detailed practicals.”

“The course leaders were all super helpful, very kind and very knowledgeable - it was a great atmosphere.”
dylwil.bsky.social
..This covers one-sample and two-sample approaches, sensitivity analyses including pleiotropy-robust methods, multivariable MR for mediation and interaction, within-family MR, MR-PheWAS and drug target MR...
dylwil.bsky.social
Our in-person Mendelian randomisation course is back at University College London this autumn. Join us in Bloomsbury, 16th-18th September 2025.

Tutors: Emma Anderson, Dylan Williams, Neil Davies
Guest lecturer: Eleanor Sanderson

onlinestore.ucl.ac.uk/conferences-...
D79 Mendelian Randomization | UCL Online Store
Abstract This course covers the fundamental developments in Mendelian randomization and gives practical explanations about how to apply MR to applied resea
onlinestore.ucl.ac.uk
dylwil.bsky.social
...many component causes of AD either directly interact or converge on the same mechanisms. So attributable fractions for them overlap and adding up combinations of can quickly sum to more than 100%. I.e. AD causes are not mutually exclusive slices of risk
dylwil.bsky.social
... And ii) this is NOT how to interpret attributable fractions for risk factors. There are plenty of other causes that account for attributable risk of AD, most notably APOE. You can't subtract fractions for a given risk factor or combo from 100% to yield "unexplained risk"
dylwil.bsky.social
Dislike this statement about AD by CARE programme grant invitation from @wellcomeleap.bsky.social and Lisa Mosconi. i) Commonplace misconception that "genetics = unmodifiable"...

#episky #medsky
dylwil.bsky.social
...Not least that something could be as common as e3 is and not be benign